Board of Directors -oud 2

Bert Tjeenk-Willink, Chairman of the Board

Bert Tjeenk Willink served as a member of the board of managing directors at Boehringer Ingelheim GmbH and he brings over 25 years experience within the pharmaceutical industry. He currently serves non-executive board positions in several pharma biotech companies e.g. Allecra Therapeutics.

Koos Koops

Koos Koops is partner of Carduso Capital. Koos is a Biochemical Engineer and he worked his entire working life in the Life Sciences sector for several companies. In 1998 he started Xendo a (bio) pharmaceutical company (consultancy and Drug Development). In 2010 he divested the Drug Development division with over 250 employees to QPS. He has substantial experience as an entrepreneur in the Life Science and more than 20 years of experience in drug development and manufacturing.

Edward van der Meer

Edward van der Meer Is Managing Director of Triade, a commercial trust organization affiliated with the University Medical Center Groningen that supports companies in the valorization and commercialization of (originally) academic concepts. Edward has been involved in the foundation and financing of numerous startups.

Jan Hendriks

Jan Hendriks is fund manager of Pharma Connect Capital. He has been involved is several pharma/life science startups in the last decades, both as investor and (interim) management roles. Jan currently also serves as CEO of InnoCore Pharmaceuticals and has previously held several general, commercial and R&D management roles in leading pharma companies. Gained his PharmD and MSc in Pharmaceutical Technology degrees from Groningen University and studied Business Administration at the same university as well as at IMD and INSEAD.